Pharmaceutical Alliance Management

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/9defcb/pharmaceutical_all)
has announced the addition of the "Pharmaceutical Alliance Management"
report to their offering.

Drive revenue through alliance success:

Nearly half of today's top-selling drugs were the result of
partnerships. Companies across the industry annually spend hundreds of
millions of dollars to utilize other firms' discovery, development and
marketing capabilities in their quests for the next blockbusters.

This pressure to maintain strong portfolios underscores the
importance of alliance management. Alliance management is a crucial
step in the deal-making process. But it is here that many deals fall
apart. At this stage, the burden rests on alliance management
personnel to keep things running smoothly. Ensuring a thriving
collaboration is a daunting responsibility requiring many parts -
ample organizational support, efficient project coordination, and
constant, open communication.

Companies that excel in alliance management position themselves to
win new deals. Those organizations that show a penchant for successful
collaborations will attract other companies looking for strong allies
- in the process filling critical portfolio holes and penetrating
exciting new markets.

Pharmaceutical Alliance Management focuses on overcoming post-deal
management challenges. Findings and interviews with pharma and biotech
industry leaders provide proven, successful approaches for partnership
success.

-0-
*T
The report instructs alliance managers on how to:

- Develop a robust alliance management strategy
- Gain key stakeholders' support and organizational resources
- Cultivate deeply rooted partner relationships
- Identify and eliminate problem areas
- Monitor alliance health
- Attain partner-of-choice status

Report Metrics
Pharmaceutical Alliance Management contains structure, resource, and
process data collected from more than 50 companies. Metrics include
the following:

- Resource support for alliance management groups
- Prevalence of dedicated alliance management functions, by company
size
- Levels of historical deal satisfaction
- Underlying reasons for unsuccessful deals
- Key deal challenges
- Inbound deals: functions involved in post-deal day-to-day activities
- Outbound deals: functions involved in post-deal day-to-day
activities
- Use of alliance health surveys
- Tools of the alliance health department
- Surveyed companies' communication models
- Steps to partner-of-choice status

Key Topics Covered:

Executive Summary
Profiled Companies
Methodology and Definitions
Business Development: Five Principles for Success
Alliance Management
Formal Alliance Management Groups
Alliance Health and Conflict Resolution
Conflict Resolution
Coordinating Project Management
Becoming a Partner of Choice

Companies Mentioned:

- Abbott Labs
- Ablynx
- ADVENTRX Pharmaceuticals
- Allergan
- Altus
- Amgen
- Amylin
- AstraZeneca
- Bayer Schering
- Biogen Idec
- Boehringer-Ingelheim
- Bristol-Myers Squibb
- Caprion Proteomics
- Celgene
- Cancer Research Technology
- Compugen
- CytRx
- DSM
- Eisai
- Eli Lilly
- Epix
- Eurand
- Genentech
- GlaxoSmithKline
- Implicit Bioscience
- Janssen-Cilag
- King Pharmaceuticals
- Lexicon
- MedImmune
- Merck & Co.
- Merck Serono
- Nerviano Medical Sciences
- Neurochem
- Neurogen
- Novartis
- Novo Nordisk
- NPS
- Onyx
- Pfizer
- Primus
- Procter & Gamble
- Purdue Pharma
- Roche
- Sanofi-Aventis
- Solvay
- Valeant Canada
- Vifor
*T

For more information visit
http://www.researchandmarkets.com/research/9defcb/pharmaceutical_all

Research and Markets
Laura Wood, Senior Manager, press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Copyright Business Wire 2008